PSP94 diagnostic reagents and assays

Details for Australian Patent Application No. 2006257671 (hide)

Owner Ambrilia Biopharma Inc.

Inventors Du Ruisseau, Pierre; Panchal, Chandra J.; Reeves, Jonathan; Tanner, Jerome Edward

Agent FB Rice

Pub. Number AU-A-2006257671

PCT Pub. Number WO2006/133560

Priority 11/154,673 17.06.05 US

Filing date 14 June 2006

Wipo publication date 21 December 2006

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 5/16 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/133560 Priority application(s): WO2006/133560

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006257678-Helix 12 directed non-steroidal antiandrogens

2006257670-Reversible inhibitors of monoamine oxidase A and B